These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25197640)

  • 21. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion.
    Spataro R; Kousi M; Farhan SMK; Willer JR; Ross JP; Dion PA; Rouleau GA; Daly MJ; Neale BM; La Bella V; Katsanis N
    Hum Genomics; 2019 Apr; 13(1):19. PubMed ID: 30992063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.
    Behrens MI; Brüggemann N; Chana P; Venegas P; Kägi M; Parrao T; Orellana P; Garrido C; Rojas CV; Hauke J; Hahnen E; González R; Seleme N; Fernández V; Schmidt A; Binkofski F; Kömpf D; Kubisch C; Hagenah J; Klein C; Ramirez A
    Mov Disord; 2010 Sep; 25(12):1929-37. PubMed ID: 20683840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis.
    Schmutz I; Jagannathan V; Bartenschlager F; Stein VM; Gruber AD; Leeb T; Katz ML
    Mol Genet Metab; 2019 May; 127(1):95-106. PubMed ID: 30956123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H
    Fujii T; Nagamori S; Wiriyasermkul P; Zheng S; Yago A; Shimizu T; Tabuchi Y; Okumura T; Fujii T; Takeshima H; Sakai H
    Nat Commun; 2023 Apr; 14(1):2174. PubMed ID: 37080960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neurons.
    Matsui H; Sato F; Sato S; Koike M; Taruno Y; Saiki S; Funayama M; Ito H; Taniguchi Y; Uemura N; Toyoda A; Sakaki Y; Takeda S; Uchiyama Y; Hattori N; Takahashi R
    FEBS Lett; 2013 May; 587(9):1316-25. PubMed ID: 23499937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
    Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
    Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation.
    Inzelberg R; Estrada-Cuzcano A; Laitman Y; De Vriendt E; Friedman E; Jordanova A
    J Parkinsons Dis; 2018; 8(3):399-403. PubMed ID: 29966207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.
    Li G; Zhang Z; Xia H; Yang X
    Med Sci Monit; 2014 Nov; 20():2177-82. PubMed ID: 25374329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome.
    Grünewald A; Arns B; Seibler P; Rakovic A; Münchau A; Ramirez A; Sue CM; Klein C
    Neurobiol Aging; 2012 Aug; 33(8):1843.e1-7. PubMed ID: 22296644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal.
    de Tezanos Pinto F; Adamo HP
    Neurochem Int; 2018 Jan; 112():108-113. PubMed ID: 29169913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
    Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A
    Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis.
    Rayaprolu S; Seven YB; Howard J; Duffy C; Altshuler M; Moloney C; Giasson BI; Lewis J
    Mol Cell Neurosci; 2018 Oct; 92():17-26. PubMed ID: 29859891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models.
    Park JS; Koentjoro B; Davis RL; Sue CM
    Parkinsonism Relat Disord; 2016 Jun; 27():67-73. PubMed ID: 27039055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.
    Santoro L; Breedveld GJ; Manganelli F; Iodice R; Pisciotta C; Nolano M; Punzo F; Quarantelli M; Pappatà S; Di Fonzo A; Oostra BA; Bonifati V
    Neurogenetics; 2011 Feb; 12(1):33-9. PubMed ID: 20853184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
    Schneider SA; Paisan-Ruiz C; Quinn NP; Lees AJ; Houlden H; Hardy J; Bhatia KP
    Mov Disord; 2010 Jun; 25(8):979-84. PubMed ID: 20310007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.
    Brüggemann N; Hagenah J; Reetz K; Schmidt A; Kasten M; Buchmann I; Eckerle S; Bähre M; Münchau A; Djarmati A; van der Vegt J; Siebner H; Binkofski F; Ramirez A; Behrens MI; Klein C
    Arch Neurol; 2010 Nov; 67(11):1357-63. PubMed ID: 21060012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9.
    Usenovic M; Krainc D
    Autophagy; 2012 Jun; 8(6):987-8. PubMed ID: 22561922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis for DJ-1 in sporadic and familial parkinsonism: screening strategy in parkinsonism.
    Tomiyama H; Li Y; Yoshino H; Mizuno Y; Kubo S; Toda T; Hattori N
    Neurosci Lett; 2009 May; 455(3):159-61. PubMed ID: 19429112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.